Health Care Transition for Adolescents and Young Adults With Pediatric-Onset Liver Disease and Transplantation: A Position Paper by the North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition : Journal of Pediatric Gastroenterology and Nutrition

Secondary Logo

Journal Logo

Societal Papers: Hepatology

Health Care Transition for Adolescents and Young Adults With Pediatric-Onset Liver Disease and Transplantation: A Position Paper by the North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition

Vittorio, Jennifer MD*; Kosmach-Park, Beverly DNP; King, Lindsay Y. MD, MPH; Fischer, Ryan MD§; Fredericks, Emily M. PhD; Ng, Vicky L. MD; Narang, Amrita MD#; Rasmussen, Sara MD**; Bucuvalas, John MD††

Author Information
Journal of Pediatric Gastroenterology and Nutrition 76(1):p 84-101, January 2023. | DOI: 10.1097/MPG.0000000000003560


Advances in both medical therapies and pediatric liver transplantation (LT) have resulted in a greater number of adolescent and young adult (AYA) patients entering adult-centered hepatology and transplant services. There are an estimated 1500–1800 solid organ transplantation (SOT) recipients between the ages of 16 and 22 in the United States (1,2). Based on Organ Procurement and Transplantation Network data (September 2021) nearly 18,000 LTs have been performed on recipients less than 18 years of age while the exact prevalence of AYA with chronic liver disease (CLD) remains unknown. There is an increased risk for medical complications and morbidity following transfer from pediatric to adult health care services in patients with childhood-onset chronic illness (3–5). Despite this inherent risk, there has been no formal, standardized approach to transition planning for pediatric patients with CLD and transplantation.

Health care transition (HCT) is the process of changing from a pediatric to an adult model of health care (6). The goal of a transition program is to help facilitate this process and optimize the likelihood of sustained well-being in young adults by fostering their ability to achieve physical, social, and psychosocial potential (1,6,7). Transfer of care is an event, or the purposeful, planned movement of a patient from pediatric to adult health care facilities (8). For most adult LT recipients, 20–25-year patient and allograft survival equates with a full life. In stark contrast, 20–25 years brings a pediatric recipient to young adulthood, a time of increased risk and vulnerability. This risk appears to intensify approximately 10 to 15 years after transplantation, right around the time of HCT (9). Ineffective transition increases the risk of chronic rejection and graft failure resulting in higher health care costs, a diminished ability to perform activities of daily living and maintain employment, and augmented use of scarce resources such as organs for retransplantation (5,6,10).

The purpose of this position paper is to provide the framework for a structured, multidisciplinary approach to transition planning for AYA with CLD and LT that will result in improved adherence, self-management skills, and long-term medical outcomes, similar to those observed in primary care practices (4). In addition, the authors seek to emphasize the importance of partnership between pediatric and adult colleagues. The transition process does not end at the time of transfer but must continue throughout early adulthood. Continued multidisciplinary efforts in the adult practice are essential for long-term success. To date, there has been no formal position statement from the North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) acknowledging the importance of HCT for AYA following LT. Joint consensus guidelines in collaboration with the American Society of Transplantation (AST) are presented to facilitate this mission of a standardized, multidisciplinary approach to HCT spanning across both pediatric and adult transplant and hepatology centers. This practice may allow for decreased rates of rejection, graft loss, and an improvement in long-term clinical outcomes.


Advances in medical and surgical treatment have also led to an increasing number of patients with CLD surviving into adulthood and transitioning to adult care. The true prevalence of pediatric liver disease in the United States is unknown, but it is estimated that there are approximately 15,000 hospitalizations each year attributed to complications of CLD (11). The etiology of CLD in childhood is significantly different when compared to adult-onset CLD. These patients require life-long care for ongoing medical management, progressive portal hypertension (especially during pregnancy), and the possibility of hepatic deterioration or development of hepatocellular carcinoma requiring LT. A summary of pediatric-onset CLD and recommendations for ongoing surveillance are provided in Table 1.

Summary of pediatric-onset chronic liver disease and ongoing surveillance: a quick reference guide for adult providers


In discussion with members of the NASPGHAN hepatology committee and the AST Liver and Intestinal Community of Practice, it was deemed necessary to provide a guiding document addressing key elements of the transition of care process with emphasis on the importance of partnership between pediatric and adult providers. A multidisciplinary working group with expertise in HCT was formulated. Members included both pediatric and adult hepatologists, transplant surgeons, advanced practice providers, and psychologists caring for patients with pediatric-onset liver disease and transplantation.

Relevant literature was reviewed using PubMed/MEDLINE/Google Scholar databases applying the following terms: HCT, transition of care, transfer of care, pediatric liver disease, pediatric LT, adherence, transition readiness, emerging adulthood, AYAs, quality of life, transplant outcomes, retransplantation. Literature searches were conducted through June 2021. Non-English literature was excluded. Sections were completed by individual authors with review and editing of each draft by the coauthors. The available literature and expert opinion were used by the authors to formulate suggested guidance for each section. These recommendations were modified and ultimately agreed upon by the multidisciplinary HCT working group members via virtual meetings and electronic communications. Through group consensus, reference tables and a “Post-Transfer Self Care and Skills Assessment for Young Adults” (Table 4) were created. A formal grading method was not used.


Pediatric Providers

Barriers to transition from pediatric to adult care should include reflections by the pediatric provider (Fig. 1) (12). Pediatric providers are often considered “family” by patients and parents, and providers may struggle with “letting go” of this long-standing and unique relationship leading to difficulties in relinquishing care (13,14). Pediatric provider ambivalence or negative beliefs surrounding adult care may inadvertently communicate to AYAs and their families that transfer of care is something to be feared. The unintended consequences of such uniquely strong attachments between families and their pediatric providers may contribute to challenges or impaired ability for pediatric graduates to develop new relationships with adult providers (3), thereby delaying preparation for transfer (15). Studies have also reported that pediatric providers are overly accommodating and engage in “hand holding” behaviors, thereby interfering with the development of age-appropriate self-management skills (16).

Complex interplay of factors impacting health care transition.

Adult Providers

Adult providers may lack sufficient knowledge and familiarity in caring for young adults in various stages of development. A poor understanding of the impact of childhood chronic disease on development, insufficient training in the management of congenital diseases, and a lack of formal training in adolescent medicine, have all been cited as barriers to transition at the level of the adult provider (17). In addition to a lack of familiarity and exposure, the busy and faster-paced adult practice model which places emphasis on disease management, rather than a holistic, family-centered focus, has also been perceived as a significant barrier to HCT. Providers in busy adult practices may have limited time to devote to the young adult and their family (1).

Adolescent and Young Adults

AYA SOT recipients demonstrate significant levels of executive dysfunction (18) particularly in skills necessary for planning, organizing, initiating, and maintaining future-oriented problem-solving. It should be noted that the prefrontal cortex, which is responsible for executive functions such as decision-making, organization and planning, and impulse control, is remodeled during adolescence. These neurodevelopmental changes continue until about 25 years of age (19,20).

Pediatric transplant recipients experience increased levels of emotional difficulties, most commonly depression and anxiety, as compared to their healthy peers (21), and these psychological factors can negatively impact patient adherence (22,23). It is of critical importance to recognize and identify barriers to adherence. Potential barriers that may be mitigated before transferring care include, but are not limited to, access to care, health literacy, and challenged cognitive or executive functioning. Neighborhood deprivation is another contributing factor that may increase nonadherent behaviors and jeopardize best outcomes (24).

System Barriers

Having adequate health insurance coverage during young adulthood can be a significant system barrier during transition. Although teens with disabilities and chronic conditions often have access to health insurance coverage, transition to adulthood is a time when coverage is often insufficient or non-existent (25).

Pediatric hepatology and transplant recipients should have access to a mental health specialist with expertise in adolescents with chronic illness. Transferring care to an adult transplant or hepatology center which offers these services is a challenge as there is a severe shortage of mental health professionals in the United States (26).

Best Practice Recommendations and Summary

  1. Barriers to transition are multifaceted and include individual, family, and system-wide factors.
  2. Transition planning should be initiated by the pediatric team in early adolescence.
  3. Pediatric hepatology and transplant recipients should have access to a mental health specialist with expertise in adolescents with chronic illness.
  4. Barriers to HCT are best overcome by a multidisciplinary, standardized approach to transition planning with an emphasis on partnership and collaborative practice between pediatric and adult providers.


A Structured Approach Utilizing the Six Core Elements of Health Care Transition™

A recent systematic literature review of youth with special health care needs to be reported that a structured transition program is associated with improved health, patient experience, and utilization of health care (Table 2) (30). Got Transition©, a federally funded national resource center on HCT, provides guidelines for program development through The Six Core Elements of Health Care Transition™ as recommended by the AAP/AAFP/ACP Clinical Report on HCT (31). These elements define a sequential clinical process with tools and templates for use by pediatric and adult practices. Quality improvement using the Six Core Elements of Health Care Transition™ has resulted in the development of a systematic clinical transition process in pediatric and adult academic primary care practices. Implementation of this system may improve the delivery of transition services and result in important long-term gains in patient-centered outcomes when incorporated into both pediatric and adult hepatology and transplant practices. Each core element and its applicability to transitioning youth with CLD and LT is discussed. An algorithm for HCT is summarized in Figure 2.

“Six Core Elements of Transition™” for adolescents and young adults (AYA) with pediatric-onset liver disease and transplantation
Health care transition (HCT) algorithm for adolescents and young adults with pediatric-onset liver disease and transplantation. Adapted from: Transitioning Youth to an Adult Health Care Clinician; Six Core Elements of Health Care Transition™ 3.0 1© 2020 Got Transition®

Transition Policy

The initial step of an HCT program is policy statement development to formalize program goals and reflect a systems approach to transition. Input from the hospital system, the medical team, youth, and parent/caregiver should reflect a consensus on the approach to HCT including target age range for initiation of the process, information to be communicated to the adult team, how the youth will be prepared for the changes of privacy and consent that occur at 18 years of age, and if needed, information and assistance on supported decision-making and guardianship.

Tracking and Monitoring

Developing a flow sheet to track the youth’s progression through HCT is an essential component of program design and provides data on overall program participation, access to HCT tools and services, the timeline for transfer, and outcomes after transfer. A tracking record through the EMR can be created and maintained to follow the youth’s participation and completion of each core element. Sample flow sheets are available on the Got Transition© website ( Additionally, tracking HCT aligns with quality improvement projects such as monitoring the percentage of patients enrolled in the HCT program and core element completion.

Transition Readiness

Being “ready” for transfer to adult care is a critical outcome of HCT. Readiness is defined as making specific decisions and operationalizing a plan to build the capacity of the youth, parent, and health care providers to participate in HCT from the start of the process through transfer (32). Participation in a transition readiness skills program for LT recipients was reported to improve outcomes after transfer to adult care in regard to adherence in taking medications and attending post-transfer clinic appointments (33).

Through TRA, the provider, youth, and parents/caregivers work collaboratively to identify and discuss self-care goals, plan strategies to achieve these goals, and operationalize skill-building activities. TRA should be completed at enrollment in the transition program and repeated at routine intervals to assess progress, evaluate strengths and weaknesses, and to update the plan of care for achieving self-efficacy and progressive independence in care (34). The final TRA should be shared with the adult team and included in the transfer package. TRA can be completed with validated tools used for chronic conditions, such as the Transition Readiness Assessment Questionnaire (35), the UNC STARx Questionnaire (36), or the Got Transition© Readiness Assessment for Youth (34). Although these tools are frequently cited in the transplant transition literature, they are not specific to LT or CLD. There are currently no validated TRA tools for AYA LT recipients, although transition templates have been developed through the AST that can be adapted to the needs and population of individual transplant centers. A checklist and a qualitative interview tool for early, middle, and late adolescence and an Action Plan for the teen and parent/caregiver have been developed ( Reliability and validity have not yet been established.

Transition Planning

Through collaboration with youth, parents/caregivers, and pediatric and adult health care providers, a transition plan should be established to set goals and target dates within the transition process. The plan of care includes routinely scheduled TRA, updated goals and an action plan to achieve those goals. Transfer planning also involves developing a medical summary for transfer, an emergency care plan, and preparing the youth and parents for the changes in privacy and consent that occur at age 18. Youth should be oriented to consents for treatment, advanced directives, and release of medical information. Determinations are made for legal decision-making support and guardianship if needed. Medical insurance, community support services, and specialty practices for the youth’s needs after transfer should also be established. Sample templates for these processes are available through Got Transition© (

Transfer of Care

Coordination of care and communication are essential components of HCT. Through pediatric and adult team collaboration, a transfer “package” should be compiled containing a medical summary, the final TRA, an updated plan of care, verification of insurance coverage, an emergency care plan, legal documents (if needed), and a medical condition fact sheet. Maintaining a transfer checklist is helpful. Following confirmation of the first adult provider appointment, the teams should participate in a final review of care and confirm the pediatric provider’s responsibility for care until the youth is seen by the adult provider. A virtual “Meet and Greet” can be scheduled before the first adult clinic appointment for the young adult to meet members of the adult team, ask questions about transfer, and to experience pediatric and adult team collaboration to optimize transfer of care (Telehealth Toolkit []). Collaboration has been reported as a factor of resilience for youth during transition (37).

Transfer Completion

The final core element assesses HCT by confirming that care has been established with an adult provider, evaluates the youth’s experience with transition, and assesses outcomes. The pediatric team should confirm the youth’s attendance at the first adult provider appointment and have a plan on how to work with the youth and adult provider if the youth fails to attend the appointment. Measuring health outcomes after transfer as well as eliciting feedback from the youth and parents about their experience may contribute to transition program improvements. Communicating with the adult team for feedback on the transfer event and to offer consultative services may help improve and streamline the transfer process while encouraging continued collaboration and growth among the stakeholders.

With increasing evidence that a structured and formalized transition program may improve outcomes in youth with chronic conditions, The Six Core Elements of Health Care Transition™ comprehensively provide the structure and tools for developing goals, interventions, assessment, and quality improvement analysis in HCT and are applicable to AYA with CLD as well as LT recipients. Additionally, the educational needs of parents/caregivers should be included in program development with a focus on understanding how to create, provide, and encourage opportunities for youth to increase independence in health care. An adaptation of the Six Core Elements pertaining to AYA with pediatric-onset liver disease and transplantation is summarized in Table 2.

Best Practice Recommendations and Summary

  1. A structured transition program is associated with improved health outcomes, patient experience, and utilization of health care.
  2. The Six Core Elements of Health Care Transition™ are applicable to AYA with CLD as well as LT recipients and should be utilized to establish a HCT program.
  3. An adaptation of the Six Core Elements pertaining to AYA with pediatric-onset liver disease and transplantation is summarized in Table 2.
  4. Regular assessment of transition readiness utilizing TRA tools is an essential component of transition planning.


Transition Focus Areas and Assessment of Transition Readiness

Although there is evidence that a structured transition program improves outcomes for youth transitioning to adult providers (30), a better understanding is needed of the health topics, skill-building strategies, and behavior skills that are most closely associated with positive outcomes after transfer. Knowledge of the youth’s medical condition and self-care skills are almost universally cited in descriptions of HCT. In a systematic review of transition programs in chronic illness, components of HCT were generalized into 3 categories: planning for transition, transfer assistance, and integration into adult care. Planning for transition included readiness assessment and education that focused on disease knowledge and self-care skills (38). Examples of these may be found in Table 3.

Suggested topics for health care transition and assessment of transition readiness

ESPGHAN and EASL published a position paper proposing a transition process for youth with liver disease (39). In regard to preparation and training during transition, the recommended educational topics included an understanding of the youth’s liver disease, symptoms and rationale for treatment, monitoring strategies, treatment-related problems (side effects of medications and treatments; adherence), sexuality, and healthy lifestyle (immunizations, weight control, and risky behaviors).

The validated transition tools commonly cited in the literature focus on the youth’s chronic health condition and self-care skills. The Got Transition© ( and Transition Readiness Assessment Questionnaire readiness questionnaires assess knowledge of the health condition, self-care skills, tracking health issues, talking with providers, insurance, support, and health advocacy (35). The UNC STARx additionally assesses reproductive health, trade/school status, and nutrition (36).

Although some transplant HCT programs report better outcomes following educational interventions, this is not consistently observed and associations with specific aspects of transition and transition topics are not known. With continued program development and outcomes monitoring during transition and after transfer, it will be important to assess the educational topics and interventions that can affect outcomes after transfer to adult providers. Recommendations for topics to be included in educational sessions with HCT based on current literature are included in Table 3 (29,33,40–42).

The HCT Multidisciplinary Team

HCT requires a coordinated, multidisciplinary effort with a core transition team comprised of hepatologists, advanced practice providers, surgeons, pharmacists, nutritionists, social workers, nurses, psychologists, and psychiatrists from both the pediatric and adult teams. Consideration should also be made for the inclusion of a neuropsychologist and financial coordinators. The composition of individual HCT programs is center-specific and will largely depend upon the availability of local personnel and support at each center.


Given the myriad of patient and family psychosocial stressors, psychologists are valuable members of the pediatric hepatology team. Psychologists working within outpatient specialty clinics tend to provide brief psychosocial assessment with emphasis on identifying patients in need of additional intervention services (27). Psychologists are also likely to focus on issues related to nonadherence (e.g. mood, sleep issues, lack of parental monitoring), learning and school-based concerns (28), risk assessments and safety planning, and promoting readiness for transition to adult-based care (33). With respect to HCT, psychologists can routinely assess self-management skills, track and monitor progress toward goals, and develop strategies to mitigate modifiable barriers to transferring care.

Social Workers

Social workers are an instrumental part of the HCT team and help to address socioeconomic determinants of health, including housing, transportation, and food insecurities. They are familiar with the availability of local and statewide resources and supportive services. Including social workers in HCT interventions may reduce barriers by providing improved linkages to health care and community-based services as well as greater psychosocial support leading to sustainable positive health outcomes (43). Prior studies have demonstrated that increased social work support services are associated with lower total hospital costs and increased probability of physician follow-up (44,45).

Transplant Pharmacists

The United Network for Organ Sharing (UNOS) and the Centers for Medicare and Medicaid Services specifically cite the transplant pharmacist as a mandatory component of the multidisciplinary care team (46,47). The clinical transplant pharmacist may make a positive impact during HCT through medication management, patient medication education, motivational interviewing, and by suggesting strategies to promote medication adherence. Pharmacists can identify patient-specific risk factors for nonadherence and tailor interventions to modify these risk factors in each patient (48). Pharmacists can also help facilitate continuity of prescriptions as the AYA changes providers and health care systems.

Nursing and HCT Coordinators

The Pediatric Committee of the AST has recommended that pediatric transplant recipients have a designated HCT coordinator to facilitate the transition process (1). According to national policy statements, an identified care coordinator is an essential component to transitional care (49,50). Nurse practitioners, clinical nurse specialists, and certified clinical transplant coordinators (CCTC) are in a position to take a leadership role in transitional care programming (51). Specifically, a CCTC can assist in patient education about self-management skills, facilitate communication regarding transition milestones, and anticipate barriers related to the transfer from pediatric to adult-centered care. As transition coordinators, CCTCs can assist with the development of a written HCT plan that sets forth a timeline for the achievement of self-management skills to promote independence in health care. Transition coordinators can also prepare parents for their role in HCT by providing them with strategies to increase the adolescent’s responsibility for health care tasks in a developmentally appropriate manner (52). Transplant nurses and transition coordinators are likely the primary facilitators of monitoring the transition process and the transfer of care.

Adult Providers

The adult transplant team should be engaged early in the transition process whenever feasible. Early integration in care will help to familiarize adult providers with this unique patient population and allow for opportunities to participate in education and assessment of transition readiness. This provides an opportunity for patients to meet with the adult team while still under the care of pediatric providers. Adult providers can help clarify differences in the approach to patient care under the adult care model. This may help to assuage patient fears and anxiety that often surround transfer of care by allowing them to become better acquainted with their new care team. The role of the adult transplant team and continuation of the HCT process is discussed in further detail below.

Best Practice Recommendations and Summary

  1. Recommended topics for HCT educational sessions are summarized in Table 3.
  2. HCT requires a coordinated, multidisciplinary team comprised of hepatologists, advanced practice providers, surgeons, pharmacists, nutritionists, social workers, nurses, psychologists, and psychiatrists from both the pediatric and adult teams.
  3. HCT is a time and resource-intensive undertaking that lacks the recognition, support and reimbursement necessary for program development and outcomes assessment.
  4. Widespread implementation of comprehensive HCT programs will require the endorsement and support from governing organizations such as NASPGHAN and AST.


The transition process does not conclude when the AYA presents for their first adult office visit. Transfer of care is merely one component of HCT which will need to be continued by the adult team throughout young adulthood. Although there is no one ideal model for post-transfer care, an adult team approach that supports ongoing development of self-management skills adapted to the youth’s unique needs is essential. Many young adults will transfer to adult centers that are affiliated with a specific pediatric program, thereby facilitating opportunities for joint transition programs and ongoing collaborations. Changes in insurance coverage, and/or opportunities for employment or post-high school education, however, may necessitate migration away from prior pediatric providers. Even in the absence of an affiliated pediatric center, the adult LT or hepatology program must be prepared to accept these patients from their prior pediatric centers. The Six Core Elements of Health Care Transition™, previously detailed, provide a framework for adult hepatology and transplant teams to continue the transition process within the adult setting. These Core Elements are outlined in Table 2 and may help guide the adult provider’s approach to HCT with suggested goals and strategies.

At the initial visit, the adult team should address any concerns the young adult may have in transferring care and discuss potential differences between pediatric and adult care practices. The adult provider and young adult should clearly and mutually establish the method and expectations of routine communication between appointments. Youth should be oriented to confidentiality issues, release of medical information, shared decision-making, and having an advanced directive. Discussions surrounding medical insurance, any anticipated changes in coverage, and the need for community services and other referrals are also warranted. It may also be helpful to complete a self-care skills assessment at the initial visit and periodically thereafter (Table 4).

Post-transfer self-care and skills assessment for young adults

The initial transfer of care appointment and labs should be scheduled within an appropriate time frame, ideally within 3 months from the last pediatric appointment. In a single center study of 31 patients with CLD and/or LT who were transferred to an adult service, 47% of patients were seen within 2–6 months following their last pediatric visit and 20% were not seen for 6–12 months. The Emergency Department (ED) was the point of first contact with adult services for 20% of patients and 19% reported being out of medications during this transition (10). These findings highlight the importance of scheduling the initial transfer visit within an appropriate time frame based on the youth’s medical status, last pediatric contact, and level of adherence. It is also essential to ensure that the pediatric team is responsible for the patient’s ongoing care until the youth attends the first appointment at the adult center. A multidisciplinary team approach with care coordination is needed to successfully integrate these young adults into the adult health care system.

Adult providers caring for young adult LT recipients should also be familiar with topics that may not be routinely addressed in an otherwise typical follow-up visit. These topics include sexual and reproductive health (contraception, avoidance of teratogenic medications in females of childbearing age), risk-taking behaviors (alcohol and tobacco use, vaping, street drugs and cannabis, tattoos), and long-term medication side effects or comorbidities including skin cancer, hypertension, diabetes, hyperlipidemia, and bone health. Psychology-based screening tools are available that can assist in structuring visits with youth to assess and address some of these issues during adult clinic appointments. HEADS (Home, Education, Activities, Drugs, Sexuality) or THRxEADS (Transition, Home, Medication and Treatment, Education, Activities and Affect, Drugs, and Sexuality) are easily remembered mnemonic screening tools that were developed for adolescents, but are also applicable to young adults (53). Adult providers should consider adding these tools to their routine assessment of LT or CLD patients during clinic appointments.

Utilizing The Six Core Elements of Health Care Transition™, adult transplant and hepatology centers can develop interventions to continue the transition process in adult practice. The adult perspective of HCT should be a multidisciplinary effort with a holistic approach to patient care focusing not only on disease processes but also on psychosocial and behavioral aspects of care.

Best Practice Recommendations and Summary

  1. The transition process does not conclude at the time of transfer.
  2. Transfer of care is one component of HCT which will need to be continued by the adult team throughout young adulthood.
  3. Adult transplant and hepatology centers should utilize The Six Core Elements of Health Care Transition™ to develop interventions to continue the transition process in the adult practice.
  4. Adult providers should complete a self-care skills assessment at the initial visit and periodically thereafter (Table 4).
  5. HCT in the adult practice should be a multidisciplinary effort with a holistic approach to patient care focusing not only on disease processes but also on psychosocial and behavioral aspects of care.


The lack of a standardized approach to HCT has led to difficulties in identifying successful outcomes measures. These outcomes must look beyond mere patient and graft survival and gauge important measures such as adherence, health care costs, and health-related quality of life (HRQOL). Objective, reliable metrics exist to assess allograft health, adherence, and complications of immunosuppression. Attention should also be made to establish such metrics for determinants of HRQOL. Consistent and reliable outcomes measures are critical to drive strategies to help improve the transition process and best outcomes. Proposed outcomes measures are summarized in Table 5.

Summary of successful outcomes measures for health care transition (HCT)

Medical Outcomes

The overarching goal for children who undergo LT is for sustained well-being, a goal directly dependent on ensuring allograft health and avoiding the complications of immunosuppression. A query of the UNOS database revealed that late allograft loss and late mortality occurred in 10-40% and 20-60% of patients respectively. The former is attributed most commonly to immune-mediated injury, arguably too little immunosuppression, and the latter to infection, a result of too much immunosuppression (9,54). Even in the setting of normal liver function tests, silent allograft damage is detected in almost 50% of stable, long-term pediatric LT recipients. For allograft health, liver tests are neither sensitive nor specific, so direct or indirect assessment by liver histology or vibration controlled transient elastography, is required and soon to be validated, respectively. Complications of immunosuppression including cancer, impaired renal function, and risk of cardiac disease are also critical metrics in assessing medical outcomes.


Adherence is defined as the extent to which an individual’s behavior corresponds with the recommendations of the health care team. Variation in tacrolimus levels predict allograft rejection, especially for adolescents (55). Although health care providers cannot reliably assess adherence (56), variation in immunosuppressive drug levels, the Medication Level Variability Index, can be used as a validated marker of nonadherence (55). Given that most of the pediatric LT population received organs before age 5, transition and transfer will occur during periods of increased nonadherence and at a time when silent allograft injury is prevalent.

Health Care Utilization and Costs

HCT has been associated with increased resource utilization and health care costs. These come in the form of increased ED visits, hospitalizations, procedures, and management of medical complications such as acute cellular rejection (5). Predictors of health care utilization in patients undergoing transfer are limited. Among adolescents with chronic kidney disease undergoing TRA, several patient factors, including insurance status (private vs public) and the presence of a 504 Plan or individualized education program predicted health care utilization (57). Those with private insurance had fewer ED visits and fewer inpatient stays. Interestingly, having an individualized education program or 504 plan was also predictive of decreased health care utilization. This would suggest that financial and/or educational support may improve a patient’s transition pathway. A comprehensive transition care model focused on AYA with complex care needs may serve to reduce total costs and acute care utilization among pediatric patients with CLD or LT.

Health-Related Quality of Life

HRQOL is a multidimensional construct that encompasses domains related to physical, mental, emotional, social, and functional status, and thereby highlights how an individual’s well-being is affected over time, such as after undergoing a LT. Although HRQOL has been cited as a critical outcome metric in evaluating the success of pediatric LT (58), systematic utilization in clinical practice is not universal (59).

A systematic review focusing on assessment tools and factors associated with HRQOL after pediatric LT highlighted impaired HRQOL compared with healthy age- and gender-matched controls, identified similarities to children who have undergone other SOT, and articulated factors affecting quality of life for this patient population to include nonadherence, sleep disturbances, lower school functioning, and reduced general health perception domains scores (60). Important functional outcomes unique to pediatric chronic conditions include educational needs, school performance, and school absenteeism (61).

The availability of disease-specific tools in the armamentarium of HRQOL instruments for clinical and research use opens opportunities for enhanced representation of HRQOL in this patient population. The Pediatric Quality of Life Inventory 3.0 Transplant Module (PedsQL TM) is one such disease-specific tool (62). Targeting children who are more than 1-year post isolated LT, the Pediatric Liver Transplantation Quality of Life tool is a 26-item questionnaire that can be completed by each member of a parent-patient dyad. The subdomain scores provide insight into the patient’s and parent's views on future health, including health team transition, future health problems, family finances, and social-emotional and coping/adjustment themes, with higher scores representing better HRQOL (63).

Best Practice Recommendations and Summary

  1. Outcome assessments should include important measures such as adherence, health care costs, and HRQOL in addition to patient and graft survival.
  2. Medication Level Variability Index can be used as a validated marker of nonadherence.
  3. Validated HRQOL instruments should be incorporated into standardized longitudinal surveillance and follow-up care of pediatric LT recipients to amplify the patient and parent voice.
  4. A comprehensive transition care model focused on AYA with complex care needs may serve to reduce total costs and acute care utilization among pediatric patients with CLD or LT.


Whether a patient transfers care to an adult program within the same institution or chooses to relocate to a new center or city, the transfer of care process is only as strong as the relationship between pediatric and adult providers. Clinical outcomes following transfer are contingent upon this essential partnership and vital communications. Transitioning from parent-supervised pediatric care to a patient-centered adult care model not only requires a transfer of records, but also a transfer of trust. When pediatric providers actively identify adult partners to the patient, that trust is more easily assumed.

Geography may play a role in the strength of these partnerships, and the success of transition programs within the same medical center should be compared to those that refer patients to outside centers. That said, survival measures for pediatric heart transplant recipients did not vary according to distance from the transplanting center (64). Similarly, travel time did not result in impactful delays in receipt of care or outcomes for pediatric patients undergoing particle beam therapy for medulloblastoma (65). Hence, increasing the distance a young adult travels to visit a new provider may not necessarily impact outcomes, though the potential challenge of geography should be more clearly assessed in LT patients.

Independent of location and geography continued attention to the HCT process both before and after arrival in the adult care setting is imperative. Current literature surrounding HCT is primarily derived from pediatric population studies. While it is essential that pediatric providers appreciate the need to begin the transition process early in adolescence, it is equally important that adult providers understand the need to continue these efforts throughout young adulthood.

There is a widespread misconception that transition of care is a problem tasked solely to the pediatric team to be resolved before the time of transfer. Undoubtedly, pediatric providers will need to devote considerable time and resources to address this long-standing problem and significant efforts are currently being made to attend to these gaps in patient care. But ownership is not exclusive to pediatrics. A continuation of these efforts must be assumed by the adult care team. We must increase awareness among adult providers regarding the need to continue the transition process following transfer of care to ensure that early efforts on the pediatric side are not carried out in vain. Future studies should focus on examining transition efforts on the part of adult providers and the results of these combined efforts on long-term patient outcomes.

Increased awareness and implementation will require the support and backing from governing institutions given current limitations surrounding time, resources, and funding. Early implementation is only the first step. Ongoing and continuing efforts must follow. Multidisciplinary HCT programs must become the standard of care for all pediatric CLD and LT patients both before and after transfer.

Best Practice Recommendations and Summary

  1. Clinical outcomes following transfer of care are contingent upon the relationship between pediatric and adult providers.
  2. Adult providers must appreciate the need to continue transition efforts throughout young adulthood.
  3. Multidisciplinary HCT programs must become the standard of care for all pediatric CLD and LT patients both before and after transfer.


Increased attention to the HCT process for individuals with CLD and LT is imperative. Until the importance of HCT is appropriately recognized and addressed, these patients will remain highly vulnerable to poor long-term outcomes. A focus on HCT must be routinely adopted across programs to facilitate multicenter collaborations and determine best practice. This paper outlines a framework for the implementation of a standardized, multidisciplinary approach to HCT which spans across both pediatric and adult hepatology and LT services. Successful transition can only be achieved by way of partnership between pediatric and adult providers to ensure continued success following transfer of care.


  1. Gain further recognition and support from governing organizations at the national and international level for the importance of HCT.
  2. Standardize the approach to transition of care across centers.
  3. Mandate that multidisciplinary transition programs become standard practice for all LT centers. This may require the inclusion of HCT programs in the UNOS bylaws.
  4. Increase funding for HCT.
  5. Assess the cost of HCT services and create a reimbursement (CPT) code for transition of care.
  6. Increase awareness among adult providers regarding the need for continuation of HCT following transfer of care.
  7. Expand the availability of transition resources for adult providers.
  8. Establish formal education training in transition of care (i.e. CME course)
  9. Explore the role of technology to help improve adherence and self-management skills for AYA.
  10. Identify important outcomes measures to help facilitate future research collaborations and analysis. Outcomes measures should include an assessment of changes in health care costs and HRQOL.
  11. Conduct randomized, multicenter controlled trials examining the impact of multidisciplinary transition programs on long-term patient outcomes.


1. Altfeld SJ, Shier GE, Rooney M, et al. Effects of an enhanced discharge planning intervention for hospitalized older adults: a randomized trial. Gerontologist. 2013;53:430–40.
2. Anthony SJ, Martin K, Drabble A, et al. Perceptions of transitional care needs and experiences in pediatric heart transplant recipients. Am J Transplant. 2009;9:614–9.
3. Anton CM, Anton K, Butts RJ. Preparing for transition: the effects of a structured transition program on adolescent heart transplant patients' adherence and transplant knowledge. Pediatr Transplant. 2019;23:e13544.
4. Arya G, Balistreri WF. Pediatric liver disease in the United States: epidemiology and impact. J Gastroenterol Hepatol. 2002;17:521–5.
5. Bashore L, Bender J. Evaluation of the utility of a transition workbook in preparing adolescent and young adult cancer survivors for transition to adult services: a pilot study. J Pediatr Oncol Nurs. 2016;33:111–8.
6. Bell LE, Bartosh SM, Davis CL, et al. Adolescent transition to adult care in solid organ transplantation: a consensus conference report. Am J Transplant. 2008;8:2230–42.
7. Berney-Martinet S, Key F, Bell L, et al. Psychological profile of adolescents with a kidney transplant. Pediatr Transplant. 2009;3:701–10.
8. Betz CL, Redcay G. Dimensions of the transition service coordinator role. J Spec Pediatr Nurs. 2005;10:49–59.
9. Blum RW, Garell D, Hodgman CH, et al. Transition from child-centered to adult health-care systems for adolescents with chronic conditions. A position paper of the Society for Adolescent Medicine. J Adolesc Health. 1993;14:570–6.
10. Bucuvalas JC, Alonso E, Magee JC, et al. Improving long-term outcomes after liver transplantation in children. Am J Transplant. 2008;8:2506–13.
11. Caballero A, Granberg R, Tseng KY. Mechanisms contributing to prefrontal cortex maturation during adolescence. Neurosci Biobehav Rev. 2016;70:4–12.
12. Casey BJ, Getz S, Galvan A. The adolescent brain. Dev Rev. 2008;28:62–77.
13. Chadi N, Amaria K, Kaufman M. Expand your HEADS, follow the THRxEADS!. Paediatr Child Health. 2017;22:23–5.
14. Chandra S, Luetkemeyer S, Romero R, et al. Growing up: not an easy transition-perspectives of patients and parents regarding transfer from a pediatric liver transplant center to adult care. Int J Hepatol. 2015;2015:765957.
15. Chandra S, Luetkemeyer S, Romero R, et al. Growing up: not an easy transition—perspectives of patients and parents regarding transfer from a pediatric liver transplant center to adult care. Int J Hepatol. 2015;2015:765957.
16. American Academy of Pediatrics; American Academy of Family Physicians; American College of Physicians-American Society of Internal Medicine. A consensus statement on health care transitions for young adults with special health care needs. Pediatrics. 2002;110:1304–6.
17. Cooley WC, Sagerman PJ. Supporting the health care transition from adolescence to adulthood in the medical home. Pediatrics. 2011;128:182–200.
18. Cousino MK, Schumacher KR, Rea KE, et al. Psychosocial functioning in pediatric heart transplant recipients and their families. Pediatr Transplant. 2018;22:e13110.
19. daCruz K, Cousino MK, Smith T, et al. Educational needs in families of pediatric liver and kidney transplant recipients: a quality improvement project. Pediatr Transplant. 2019;23:e13412.
20. Ekong UD, Gupta NA, Urban R, et al. 20- to 25-year patient and graft survival following a single pediatric liver transplant-analysis of the United Network of Organ Sharing database: where to go from here. Pediatr Transplant. 2019;23:e13523.
21. Fair CD, Sullivan K, Dizney R, et al. "It's like losing a part of my family": transition expectations of adolescents living with perinatally acquired HIV and their guardians. AIDS Patient Care STDS. 2012;26:423–9.
22. Ferris M, Cohen S, Haberman C, et al. Self-management and transition readiness assessment: development, reliability, and factor structure of the STARx questionnaire. J Pediatr Nurs. 2015;30:691–9.
23. Fredericks EM. Nonadherence and the transition to adulthood. Liver Transpl. 2009;15:S63–69.
24. Fredericks EM, Dore-Stites D, Well A, et al. Assessment of transition readiness skills and adherence in pediatric liver transplant recipients. Pediatr Transplant. 2010;14:944–53.
25. Fredericks EM, Lopez MJ, Magee JC, et al. Psychological functioning, nonadherence and health outcomes after pediatric liver transplantation. Am J Transplant. 2007;7:1974–83.
26. Fredericks EM, Magee JC, Eder SJ, et al. Quality improvement targeting adherence during the transition from a pediatric to adult liver transplant clinic. J Clin Psychol Med Settings. 2015;22:150–9.
27. Grady KL, Andrei AC, Shankel T, et al. Pediatric heart transplantation: transitioning to adult care (TRANSIT): feasibility of a pilot randomized controlled trial. J Card Fail. 2019;25:948–58.
28. Gray WN, Resmini AR, Baker KD, et al. Concerns, barriers, and recommendations to improve transition from pediatric to adult IBD care: perspectives of patients, parents, and health professionals. Inflamm Bowel Dis. 2015;21:1641–51.
29. Gray WN, Schaefer MR, Resmini-Rawlinson A, et al. Barriers to transition from pediatric to adult care: a systematic review. J Pediatr Psychol. 2018;43:488–502.
30. Gutiérrez-Colina AM, Eaton CK, Lee JL, et al. Executive functioning, barriers to adherence, and nonadherence in adolescent and young adult transplant recipients. J Pediatr Psychol. 2016;41:759–67.
31. Hine CE, Howell HB, Yonkers KA. Integration of medical and psychological treatment within the primary health care setting. Soc Work Health Care. 2008;47:122–34.
32. Huang J, Porterfield SL. Changes in health insurance coverage and health care access as teens with disabilities transition to adulthood. Disabil Health J. 2019;12:551–6.
33. Javalkar K, Fenton N, Cohen S, et al. Socioecologic factors as predictors of readiness for self-management and transition, medication adherence, and health care utilization among adolescents and young adults with chronic kidney disease. Prev Chronic Dis. 2014;11:E117.
34. Joshi D, Gupta N, Samyn M, et al. The management of childhood liver diseases in adulthood. J Hepatol. 2017;66:631–44.
35. Keith DS, Cantarovich M, Paraskevas S, et al. Recipient age and risk of chronic allograft nephropathy in primary deceased donor kidney transplant. Transpl Int. 2006;19:649–56.
36. Kenney LB, Melvin P, Fishman LN, et al. Transition and transfer of childhood cancer survivors to adult care: a national survey of pediatric oncologists. Pediatr Blood Cancer. 2017;64:346–52.
37. Khorassani F, Tellier S, Tsapepas D. Pharmacist's role in improving medication adherence in transplant recipients with comorbid psychiatric disorders. J Pharm Pract. 2019;32:568–78.
38. Kosola S, Ylinen E, Finne P, et al. Implementation of a transition model to adult care may not be enough to improve results: national study of kidney transplant recipients. Clin Transplant. 2019;33:e13449.
39. Lawrence ZE, Lobritto S, Chen J, et al. Adherence, medical outcomes, and health care costs in adolescents/young adults following pediatric liver transplantation. J Pediatr Gastroenterol Nutr. 2019;70:183–9.
40. Liu SM, Brooks ED, Rubin ML, et al. Referral patterns and treatment delays in medulloblastoma: a large academic proton center experience. Int J Part Ther. 2021;7:1–10.
41. McKane M, Dodd DA, Mettler BA, et al. Geographic distance from transplant center does not impact pediatric heart transplant outcomes. Prog Transplant. 2018;28:170–3.
42. Meddings J, Kerr EA, Heisler M, et al. Physician assessments of medication adherence and decisions to intensify medications for patients with uncontrolled blood pressure: still no better than a coin toss. BMC Health Serv Res. 2012;12:270.
43. Centers for Medicare & Medicaid Services (CMS), HHS. Medicare program; hospital conditions of participation: requirements for approval and re-approval of transplant centers to perform organ transplants. Final rule. Fed Regist. 2007;72:15197–280.
44. Ng V, Nicholas D, Dhawan A, et al. Development and validation of the pediatric liver transplantation quality of life: a disease-specific quality of life measure for pediatric liver transplant recipients. J Pediatr. 2014;165:547–555.e547.
45. Niazi SK, Spaulding A, Vargas E, et al. Mental health and chemical dependency services at US transplant centers. Am J Transplant. 2020;20:1152–61.
46. Ohnemus D, Neighbors K, Rychlik K, et al. Health-related quality of life and cognitive functioning in pediatric liver transplant recipients. Liver Transpl. 2020;26:45–56.
47. Parker R, Armstrong MJ, Corbett C, et al. Alcohol and substance abuse in solid-organ transplant recipients. Transplantation. 2013;96:1015–24.
48. Parmar A, Vandriel SM, Ng VL. Health-related quality of life after pediatric liver transplantation: a systematic review. Liver Transpl. 2017;23:361–74.
49. Perito ER, Squires JE, Bray D, et al. A learning health system for pediatric liver transplant: the Starzl network for excellence in pediatric transplantation. J Pediatr Gastroenterol Nutr. 2021;72:417–24.
50. Quinn SM, Fernandez H, McCorkle T, et al. The role of resilience in healthcare transitions among adolescent kidney transplant recipients. Pediatr Transplant. 2019;23:e13559.
51. Rizzo VM. Social work support services for stroke patients: interventions and outcomes. Soc Work Health Care. 2006;43:33–56.
52. Rosen DS, Blum RW, Britto M, et al. Transition to adult health care for adolescents and young adults with chronic conditions: position paper of the Society for Adolescent Medicine. J Adolesc Health. 2003;33:309–11.
53. Sagar N, Leithead JA, Lloyd C, et al. Pediatric liver transplant recipients who undergo transfer to the adult healthcare service have good long-term outcomes. Am J Transplant. 2015;15:1864–73.
54. Schmidt A, Ilango SM, McManus MA, et al. Outcomes of pediatric to adult health care transition interventions: an updated systematic review. J Pediatr Nurs. 2020;51:92–107.
55. Shaw RJ, Palmer L, Blasey C, et al. A typology of non-adherence in pediatric renal transplant recipients. Pediatr Transplant. 2003;7:489–93.
56. Shemesh E, Bucuvalas JC, Anand R, et al. The medication level variability index (MLVI) predicts poor liver transplant outcomes: a prospective multi-site study. Am J Transplant. 2017;17:2668–78.
57. Soltys KA, Mazariegos GV, Squires RH, et al. Late graft loss or death in pediatric liver transplantation: an analysis of the SPLIT database. Am J Transplant. 2007;7:2165–71.
58. Tanner AE, Philbin MM, Ma A, et al. Adolescent to adult HIV health care transition from the perspective of adult providers in the United States. J Adolesc Health. 2017;61:434–9.
59. UNOS. Attachment I to Appendix B OF UNOS Bylaws. 2009. Accessed September 2021.
60. Vajro P, Fischler B, Burra P, et al. The health care transition of youth with liver disease into the adult health system: position paper from ESPGHAN and EASL. J Pediatr Gastroenterol Nutr. 2018;66:976–90.
61. van Staa A, van der Stege HA, Jedeloo S, Moll HA, Hilberink SR. Readiness to transfer to adult care of adolescents with chronic conditions: exploration of associated factors. J Adolesc Health. 2011;48:295–302.
62. Wadhwani SI, Beck AF, Bucuvalas J, et al. Neighborhood socioeconomic deprivation is associated with worse patient and graft survival following pediatric liver transplantation. Am J Transplant. 2020;20:1597–605.
63. Weissberg-Benchell J, Zielinski TE, Rodgers S, et al. Pediatric health-related quality of life: Feasibility, reliability and validity of the PedsQL transplant module. Am J Transplant. 2010;10:1677–85.
64. White P, S. A., Shorr J, Ilango S, Beck D, McManus M. Six Core Elements of Health Care Transition™ 3.0. Washington, DC: Got Transition, The National Alliance to Advance Adolescent Health2020.
65. White PH, Cooley WC; Transitions Clinical Report Authoring Group; American Academy of Pediatrics; American Academy of Family Physicians; American College of Physicians. Supporting the health care transition from adolescence to adulthood in the medical home. Pediatrics. 2018;142(5):e20182587. Pediatrics. 2019;143:e20183610.
66. Wood DL, Sawicki GS, Miller MD, et al. The transition readiness assessment questionnaire (TRAQ): its factor structure, reliability, and validity. Acad Pediatr. 2014;14:415–22.

emerging adulthood; nonadherence; transfer of care; transitions of care

Copyright © 2022 by European Society for European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.